Search the Site


test tubes

Run-Up Analysis: ALXA, AVNR, and BIOD

publication date: Oct 25, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
As October begins to wind down, we can step back and take a look at three of the key run-up plays this month.  These are ALXA (10/11), AVNR (10/30), and BIOD (10/30).  The early sell-offs in these stocks were significant and my represent a necessary shift in the 'Run-Up" method.  Lets take a look and how these plays panned out, and see what changes we can make to capitalize on the upcoming FDA decisions throughout the remainder of 2010.

Sorry this page is available to subscribers only. 

You can also sign up for our 100% FREE Newsletter  to stay current on public webinars, special offers, and news alerts:


If you are already a subscriber, please login.

To gain access to the members only content click here to subscribe.

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.